SRTS Sensus Healthcare, Inc.

$3.15▲ +0.96% Healthcare Other
After hours $3.15▲ +0.00% Sep 11, 7:30 PM ET
Volume 8.2K Avg Volume (10D) 48.9K
Key Metrics & Fundamentals
Market Cap
$51.86M
P/E Ratio
–
Div Yield
–%
52W Range
2.66 - 5.49
% vs 50 MA
1.60%
% vs 200 MA
-15.73%
RSI-14
48.1
MACD Histogram
-0.0300
Beta (1Y vs SPY)
0.88
Free Cash Flow
-$3.14M
Gross Rev
$2.29M
Gross Profit
$769,000
EBITDA
-$3.03M
COGS
$1.52M
Operating Exp
$3.95M
Operating Income
-$3.18M
EBIT
-$3.18M
Pretax Income
-$3.06M
Net Income
-$8.75M
EPS (Diluted)
-0.53
Price & Volume History
Loading chart…
Recent News
Meta Buys Stilla.ai: What the Swedish AI Acquisition Means for META Stock
Barchart · Sep 10, 2026 4:18 PM
Sensus (SRTS) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 20, 2026 10:45 PM
Sensus Healthcare Inc (SRTS) (Q2 2026) Earnings Call Highlights: Strong Pipeline and New CPT ...
GuruFocus.com · Aug 17, 2026 7:01 PM
Sensus Healthcare, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 14, 2026 12:30 PM
Sensus Healthcare Q2 Earnings Call Highlights
MarketBeat · Aug 14, 2026 3:04 AM
Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights
Business Wire · Aug 13, 2026 8:22 PM
Sensus Healthcare to Report Second Quarter 2026 Financial Results and Hold Business Update Conference Call on August 13, 2026
Business Wire · Jul 30, 2026 8:05 PM
Financial Overview - Income Statement Quarterly

See SRTS's money flow as a full page

Social Sentiment
Avg +0.20 · 3 posts
Synthetic Risk Transfers
r/stocks · Dec 11, 2025
The post expresses skepticism about SRTs, framing them as potentially dangerous and linked to past financial crises, suggesting a bearish outlook.
negative -0.60
TradeDiscussionNewsBullish on these penny stocks
r/options · Jul 26, 2025
The author expresses a positive outlook on SRTS due to a squeeze.
positive +0.60
TradeDiscussionLook for some good leaps to buy that expire 2026
r/options · Dec 6, 2024
The author is actively considering SRTS for their LEAPS trade.
positive +0.60
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙